United States:
Podcast: SaMD Series: What Should Tech Companies Know?
23 July 2018
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Software as a Medical Device – also referred to as SaMD
– is one of the fastest growing innovations in the medical
device industry. As with any technology that experiences rapid
adoption, challenges related to intellectual property protection
often follow. In this series, we take a close look at IP
considerations that SaMD developers should be aware of as they
enter this market. In this podcast, Finnegan attorneys Susan Tull
and Cory Bell explore challenges tech companies may face when
developing SaMD.
To listen to the podcast, please click
here
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.